Maryland 2026 Regular Session

Maryland House Bill HB1323

Introduced
2/12/26  

Caption

Health Care Decisions Act - Surrogate Decision Making - Hospital Surrogate Committee

Impact

The implementation of HB1323 is expected to significantly affect hospital policies and patient care protocols. By requiring the establishment of surrogate committees, hospitals will need to develop procedures that adhere to the guidelines outlined in the bill. These include determining patient incapacity, conducting evaluations, and training committee members in bioethical principles and patient rights. This legislation could improve the quality of decision-making for unrepresented patients who are often vulnerable and in critical situations, thereby enhancing ethical standards in healthcare.

Summary

House Bill 1323, known as the Health Care Decisions Act, seeks to establish a framework for surrogate decision making within hospitals for unrepresented patients—those who lack a healthcare representative and cannot make informed decisions regarding their own care. The bill mandates that hospitals create a surrogate committee responsible for making medical treatment decisions when no one is available to act on behalf of the patient. These committees must include a diverse range of members, including healthcare professionals and patient advocates, ensuring that a multifaceted perspective is brought into the decision-making process.

Contention

However, the bill has stirred some controversy among healthcare professionals and patient advocacy groups. While supporters argue that it clarifies decision-making for unrepresented patients and reduces the risks of neglect or misinformation, critics raise concerns over the possible inadequacies of surrogate committees. Detractors fear that the quality of decisions made might be compromised due to the varying levels of experience and ethical approaches among committee members, as well as potential conflicts of interest that may arise within the healthcare system. The balance between timely decision-making and thorough ethical consideration remains a pivotal point of contention.

Companion Bills

No companion bills found.

Previously Filed As

MD HB1323

Health Care Decisions Act - Surrogate Decision Making - Hospital Surrogate Committee

MD SB987

Artificial Intelligence - Health Software and Health Insurance Decision Making

MD SB474

Health Insurance - Adverse Decisions - Notices, Reporting, and Examinations

MD HB697

Health Insurance - Artificial Intelligence, Adverse Decisions, and Grievances - Reporting Requirements

MD HB848

Health Insurance - Adverse Decisions - Notices, Reporting, and Examinations

MD HB474

Public Health - Maryland Commission on Health Equity - Advisory Committee and Hospital Reporting

MD SB129

Public Health - Maryland Commission on Health Equity - Advisory Committee and Hospital Reporting

MD SB776

Workgroup to Study the Rise in Adverse Decisions in the State Health Care System - Establishment

MD HB995

Workgroup to Study the Rise in Adverse Decisions in the State Health Care System - Establishment

MD HB905

Hospitals - Clinical Staffing Committees and Plans - Establishment (Safe Staffing Act of 2025)

Similar Bills

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

NM HJM2

Combine Standing & Interim Committees

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

OR SCR207

Establishing procedural rules for legislative branch.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

MN HC2

A House concurrent resolution relating to the adjournment of the House of Representatives and Senate until 2026.

KS HB2054

Senate Substitute for HB 2054 by Committee on Federal and State Affairs - Increasing the limits on certain campaign contributions under the campaign finance act.